Translated title of the contribution | CYP2C19 genotype-guided antiplatelet therapy in ST-segment elevation myocardial infarction patients-Rationale and design of the Patient Outcome after primary PCI (POPular) Genetics study |
---|---|
Original language | Undefined/Unknown |
Pages (from-to) | 16-22 |
Number of pages | 7 |
Journal | American Heart Journal |
Volume | 168 |
Publication status | Published - 2014 |
CYP2C19 genotype-guided antiplatelet therapy in ST-segment elevation myocardial infarction patients-Rationale and design of the Patient Outcome after primary PCI (POPular) Genetics study
T.O. Bergmeijer, P.W.A. Janssen, J.C. Schipper, K. Qaderdan, M. Ishak, R.S. Ruitenbeek, F.W. Asselbergs, A.W. van 't Hof, W.J.M. Dewilde, F. Spanó, J.P.R. Herrman, J.C. Kelder, M.J. Postma, A. de Boer, V.H.M. Deneer, J.M. ten Berg
Research output: Contribution to journal › Article › Academic › peer-review